Adaptimmune Therapeutics PLC (ADAPY) vs Jasper Therapeutics, Inc. (JSPR)
- Adaptimmune Therapeutics PLC ADAPY 0.03 0.00%
- Jasper Therapeutics, Inc. JSPR 13.68 +2.32%
Adaptimmune Therapeutics PLC and Jasper Therapeutics, Inc. are both Biotechnology companies. Adaptimmune Therapeutics PLC and Jasper Therapeutics, Inc. are of similar size ($14.8M and $14.6M). Jasper Therapeutics, Inc. has the higher net margin (0.00% vs −262.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Jasper Therapeutics, Inc. leads on 7 and Adaptimmune Therapeutics PLC on 5.
Valuation
Profitability
| Metric | ADAPY | JSPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.81% | 0.00% | 67.24% |
| Operating margin | (427.75%) | 0.00% | 0.00% |
| Net margin | (262.46%) | 0.00% | 0.00% |
| Free cash flow margin | (294.49%) | 0.00% | 0.00% |
| Return on equity | (1,349.52%) | (255.05%) | (50.28%) |
| Return on assets | 0.00% | (109.05%) | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack